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Meeting ReviewNew Developments for TGF
of interacting proteins have been identified, mostly bio-Richard W. Padgett1,2,3,4 and Garth I. Patterson2
1 Waksman Institute chemically. Many of these molecules can be demon-
strated to have an effect on TGF when overexpressed2 Department of Molecular Biology and
Biochemistry in tissue culture cells, but functional analysis of the role
of the proteins in the context of development or physiol-3 The Cancer Institute of New Jersey
Rutgers University ogy of whole organisms has lagged behind. Now that the
core of the signaling pathway is known, more attention isPiscataway, New Jersey 08854
being given to the developmental outputs of the various
ligands.
A recent FASEB meeting was held in Tucson, Arizona
Understanding TGF’s Role as a Morphogenthat encompassed TGF superfamily signaling path-
in Early Developmentways and their roles in development. This review fo-
Several TGF homologs function to set up basic bodycuses on the developmental biology presented at the
axes in early development in a broad range of organ-meeting.
isms. In many cases, the ligand acts in a morphogen
gradient: the concentration of functional ligand varies
TGF superfamily signaling molecules were first discov- along an axis, and cells respond differently to different
ered 20 years ago. Several aspects of understanding ligand concentrations, which results in asymmetry of
how these signals are transduced lagged behind other cell fates along the axis. However, C. elegans appears
signaling pathways. However, intense work over the last to be an exception, as genetic analysis has led to the
five years has led to a solid understanding of the core astonishing conclusion that no form of TGF superfamily
signaling components (reviewed in Heldin et al., 1997; signaling is required for viability or establishing major
Massague´, 1998; Patterson and Padgett, 2000; Whit- body axes or tissue types in this animal (Patterson and
man, 1998). Developmental aspects of TGF signaling Padgett, 2000).
are now beginning to get the attention they deserve. The question of how TGF-related morphogens pro-
Consequently, the field has matured to the point that a duce varied cell fates along an axis has been studied
meeting on developmental aspects of TGF was war- intensively. Several new insights into this process were
ranted. Anita Roberts and Rik Derynck organized a FA- presented at the meeting. One model is that the ligands
SEB meeting in Tucson, Arizona in July, 2001 to explore act directly (by inducing different cell fates at different
the developmental events evoked by TGF and to for- concentrations of functional ligand). A second is that
mulate future challenges. The meeting covered a wide the ligands act indirectly by sending a signal that creates
range to topics (including aspects of the core signaling a secondary signal. A. Schier (Skirball Institute, NYU)
machinery, Smad functions, extracellular regulators, presented evidence that the first model is true for Squint
patterning, and differentiation) and surveyed many (a Nodal-related ligand) signaling in zebrafish (Chen and
model organisms that are contributing to our under- Schier, 2001). First, they produced a small patch of cells
standing of TGF’s growth properties (C. elegans, Dro- that could respond directly to Squint by placing wild-
sophila, Xenopus, zebrafish, mouse). type cells in one-eyed pinhead (oep) mutant tissue.
Smads, which are the primary transducers of signals These cells responded to a high concentration of Squint
from TGF superfamily receptors, were identified based but did not produce any response to Squint outside of
on their role in several developmental systems (Dro- the oep patch. This result is not consistent with the
sophila, C. elegans, Xenopus, human pancreatic can- indirect model, in which oep cells would produce the
cers) (Baker and Harland, 1996; Hahn et al., 1996; Sav- secondary signal that could signal to other cells in a
age et al., 1996; Sekelsky et al., 1995). Biochemical Squint receptor-independent fashion. Additional sup-
characterization of Smads, primarily in tissue culture port for the direct model came from producing a clone
cells, has led to the standard model, shown in Figure 1, of oep cells at a distance from a source of Squint.
in which Smads are the primary signal transducer of These cells responded to Squint by turning on target
TGF-like pathways (see Table 1 for a description of genes, as expected if Squint acts directly over a long
terms used in this paper). This simple pathway does not range.
explain the complex phenotypic changes provoked by OEP is a zebrafish member of the CFC family of
TGF—for example, there are only eight known Smads the Nodal receptor cofactors, which includes human
in humans, yet TGF superfamily molecules have scores Cripto-1, mouse Cryptic, and Xenopus FRL-1. M. Whit-
of characterized roles in development and physiology. man (Harvard U.) presented data (in collaboration with
Most, if not all, tissues express one or more of the ap- Biogen) that shows that an EGF repeat of Cripto-1 has
proximate 37 ligands at some point in their ontogeny. A an O-linked fucose and that this modification is impor-
major way in which TGF superfamily pathways achieve tant for the ability of Cripto-1 to act in a Nodal pathway
diversity of effects is by the interaction of ligands, recep- (Schiffer et al., 2001). The receptor Notch also has an
tors, and Smads with a variety of other factors. Dozens O-linked fucose modification in its EGF repeats that is
required for its proper function in signal transduction.
The O-linked fucose of Notch is further elongated by4 Correspondence: padgett@waksman.rutgers.edu
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washing. It will be interesting to see how the concept
of memory contributes to our understanding of how the
concentration and length of exposure to ligand are inte-
grated.
When the concept of morphogen gradients was devel-
oped, it was reasonably assumed that the gradients are
established by having a source of a diffusible morpho-
gen. As we are now learning, many factors contribute
to the effective shape of the morphogen gradient. T.
Tabata (U. Tokyo) discussed work in Drosophila showing
that the novel protein, MASTER OF THICKVEINS, allows
ENGRAILED and HEDGEHOG to regulate the production
of a receptor gradient that influences how a ligand gradi-
ent is established and interpreted (Funakoshi et al.,
2001). BMP signaling in the dorsal/ventral axis in verte-
brates and Drosophila uses a surprisingly complex
means of establishing a gradient. For example, in Xeno-
pus, a morphogen, BMP4, is laid down in a uniform
expression pattern. Next, the inhibitor Chordin is laid
down in a gradient and acts by tightly binding BMP4
and preventing it from activating receptors. Finally, an
inhibitor of the inhibitor (Xolloid, a metalloprotease)
cleaves Chordin to allow BMP4 to signal; this activity
modifies the final shape of the gradient. M. Ham-
merschmidt described zebrafish mutants that support
the model above (Bauer et al., 2001). M. Oelgeschlager
(UCLA) and A. Hemmati-Brivanlou (Rockefeller U.) dis-
cussed the role of Twisted gastrulation (TSG) in the
creation and interpretation of the BMP gradient (Chang
et al., 2001; Oelgeschlager et al., 2000; Ross et al., 2001;
Scott et al., 2001; Yu et al., 1996). Clearly, TSG binds to
BMP and Chordin, but the effect of this interaction is
uncertain. Some data suggests that TSG suppresses
the ability of Chordin to block BMP signaling, while other
data suggests that TSG enhances the inhibition by
Chordin.
Another type of ligand-interacting protein has re-
ceived renewed attention. Some time ago, latent forms
Figure 1. General Scheme for TGF Superfamily Signaling of TGF were observed. In these complexes, TGF is
Secreted ligands (light blue) interact with extracellular inhibitors. In noncovalently bound to its pro region, which is cova-
the case of BMP signaling, one inhibitor is Chordin (light green). lently bound to latent TGFbinding protein (LTBP). How-Tolloid-like proteases can relieve suppression by cleaving Chordin.
ever, the biological significance of these interactionsTwisted gastrulation (yellow) is shown interacting with Chordin and
remained obscure, and there has been little evidenceligand. The consequence of this interaction is still being defined
that other ligands are complexed in a similar manner. D.(see text), but ligand is freed by some means and interacts with
receptor. Receptor kinases phosphorylate Smads, which allows Rifkin (NYU Medical School) and A. Hemmati-Brivanlou
Smads to enter the nucleus and interact with transcriptional co- provided strong evidence that these latent forms are
factors. important biologically in mouse TGF signaling and Xen-
opus Activin signaling, respectively. S.-J. Lee (Johns
Hopkins) described recent work showing that the pro
Fringe, a 1,3-GlcNAc-transferase (Irvine, 1999), but Dr. domain of myostatin can also act as an inhibitor of this
Whitman and collaborators did not observe elongated ligand (Lee and McPherron, 2001).
forms of Cripto-1 in CHO cells. However, the status M. Affolter (Biozentrum U. Basel) described complex,
of additional modifications to the O-linked fucose in negative signaling events downstream of Dpp, a BMP-
animals, if any, is unknown. like molecule in Drosophila. For some genes, activation
How do cells respond to different concentrations of is a simple consequence of direct activation by activated
ligand? Cells close to a source of ligand not only see a Mad (the R-Smad downstream of Dpp), but for others
higher concentration of the ligand, but also are exposed the pathway is more complex. Some target genes are
to ligand for a longer period of time. The integration of transcriptionally inactivated by Brinker (a homeodomain
these two factors was discussed by J. Gurdon (Well- transcriptional repressor). Mad and Schnurri (a nuclear
come CRC Institute) (Dyson and Gurdon, 1998). He pre- zinc finger protein) act together to prevent the transcrip-
sented work by P. Bourillot in his lab that indicates tion of Brinker, thereby allowing transcription of a num-
that cells have a memory of exposure to Activin. They ber of dpp target genes by relieving them from Brinker
observed that the response of Smads to Activin recep- repression (Marty et al., 2000; Torres-Vazquez et al.,
2001). Thus, some genes do not require binding of Madtors are seen many hours after Activin is removed by
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Table 1. Glossary of TGF Superfamily Siganling Pathway Components Described in This Review
Protein Comment
Ligands
TGF Stands for Transforming Growth Factor, which was the first biological activity defined for this protein.
This name is used in multiple ways. Because TGF was the first member of the superfamily identified,
TGF is used as a generic term to describe any member of the family. It is also used to describe a
subfamily of molecules that are very closely related to the original TGF.
BMP Stands for Bone Morphogenetic Protein. The original BMPs were identified as molecules that induced
ectopic bone growth. BMP is also used as a generic term to describe a subfamily of closely related
ligands.
GDF Stands for Growth and Differentiation Factor. This term was invented to name new TGF superfamily
molecules that were cloned by homology.
Activin A subfamily of the TGF superfamily.
Dpp Stands for decapentaplegic. Dpp is a Drosophila DMP, closely related to vertebrate BMP2 and BMP4.
myostatin Orginally called GDF-8. Named for its function in regulating muscle growth.
Nodal A ligand, originally identified in mouse, that controls early development in vertebrates, as well as other
events.
AMH Stands for Anti-Mu¨llerian Hormone. Also known as Mu¨llerian Inhibiting Substance.
Receptors
ALK Used to name type I receptors in vertebrates. Some receptors also have other, duplicate names.
Smads
Smad Used as a generic term to refer to the superfamily of molecules in all organisms, named for sma and
Mad in C. elegans and Drosophila, the founding members of the family. Smads are the primary signal
transducers of TGF superfamily receptors.
Mad A Drosophila Smad closely related to Smad1 and Smad5 from vertebrates.
Other
Sno/Ski Ski was originally identified as an oncogene at Sloan Kettering Institute. Sno was cloned on the basis
of homology to Ski and named in punning allusion to Ski.
Fast A family of winged helix transcription factors that participate in TGF signaling by binding to Smads.
FKBP12 Stands for FK506 Binding Protein. FK506 is an immunosuppressant drug.
FKBP12.6 A homolog of FKBP12.
to their regulatory sequences, but require Mad in this and differentiation of smooth muscles. TGF appears
to affect one or both of these processes. Efforts areindirect fashion.
C. Hill (ICRF, London) has identified a novel transcrip- underway to make double-mutant combinations be-
tween the various mutations in TGF signaling compo-tion factor complex that is produced in response to
Activin-related molecule in early Xenopus embryos. This nents. Trans-heterozygous mutants between Smad1
and Smad5 are inviable, suggesting strong interactionscomplex contains Smads and Fast-3, a new member of
the Fast family, whose founder member, Fast-1 is a of these two BMP Smads. He is also exploring the role
of non-Smad TGF signaling.component of an earlier identified Activin-induced tran-
scription factor complex (Chen et al., 1996). Functional In parallel studies, the use of cell lines induced to
differentiate are being examined. P. ten Dijke (Nether-experiments in Xenopus embryos implicate the Fast-1-
and Fast-3/Smad complexes in the convergent exten- lands Cancer Institute) described the role of TGF bind-
ing to ALK1 or ALK5 in endothelial cells. His group hassion movements of gastrulation, which are induced by
Activin and related ligands. made antibodies to the phosphorylated forms of Smad2
and Smad1/5 (Persson et al., 1998). These antibodies
are unique and valuable reagents that are widely usedNew Inroads to Development
in the field. He showed that TGF can stimulate Smad5In the past five years, many components and cofactors
or Smad2/3 through different type I receptors, with dif-of TGF signaling have been identified. In cases in which
ferent consequences for angiogenesis. A. Roberts (NIH)the components were identified biochemically, the de-
discussed hematopoeisis using HL-60 cells, which canvelopmental functions were not immediately apparent.
be stimulated by TGF to differentiate into either granu-Two major strategies for identifying new developmental
locytes or monocytes. R. Derynck (UCSF) analyzed theroles were discussed prominently at the meeting: ge-
roles of Smad3 in the differentiation of cultured mesen-netic analysis and differentiation of cells in culture.
chymal cells into osteocytes or muscle, and A. Mousta-In situations where reverse genetic analysis is avail-
kas (Ludwig Institute, Uppsala) discussed the role ofable, mutants are being examined for insights into devel-
Yin-Yang1 and Smads in differentiation of mesenchymalopmental functions of novel components. The work on
cells. Many of these studies are just underway, but theyLTBP, described above, falls into this category. In addi-
are likely to provide important insights into develop-tion, R. Lechleider (USUHS, Bethesda) described experi-
mental roles of TGF.ments in angiogenesis using various mutations of TGF
signaling components. For example, Smad1 knockout
mice show defects in allantois development and yolk Hormonal Action of TGF
J. Visser (Erasmus U., Rotterdam) and M. Matzuk (Baylorsac angiogenesis. Maturation of blood vessels requires
two phases: recruitment of muscle cells to the vessels College of Medicine) have been examining the role of
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TGF signaling in sexual differentiation in mammals. Dr. TGF’s Role in the Progression of Cancer
and Other DiseasesMatzuk presented data about a new role for GDF-9 and
TGF signaling is disrupted in several types of cancersBMP-15 in ovulation; these factors that play important
and diseases. This is not particularly surprising since it isroles in the periovulatory period (Yan et al., 2001) . Dr.
active in the formation and maintenance of many organsVisser described her efforts to identify the receptor for
and tissues and has potent growth regulatory proper-Anti-Mu¨llerian Hormone (AMH). Years ago the type II
ties. Efforts continue to understand its role in variousAMH receptor was cloned, but the type I receptor has
neoplasias and diseases and to understand mechanisti-been elusive. Interestingly, AMH can induce BMP target
cally how it contributes to these altered states. Beinggenes in cell culture, and Smad5 (a BMP pathway Smad),
able to harness its growth inhibitory properties couldbut not Smad2 (an Activin/TGF pathway Smad), are
have a major impact on possible future therapeutics,required for this response. Disruption of the BMP recep-
as normal connections between TGF and cell cycletor ALK2 with morpholinos blocked the AMH signal in
control have been lost in many cancers. J. Massague´culture, and ALK2 is expressed in AMH target cells in
(Sloan Kettering) updated us on TGF connections withvivo (Visser et al., 2001). She also observes that morpho-
cell cycle regulators p15 and p21/27 (Chen et al., 2001).linos directed against ALK2 block AMH-induced Mu¨lle-
M. Reiss (UMDNJ-Robert Wood Medical School) hasrian duct regression in in vitro cultured urogential ridges.
examined large numbers of breast and colon cancersThese results suggest that ALK2 functions as an AMH
and has found that phosphorylated Smad2 is expressedtype I receptor in vivo.
in over 90% of them, suggesting that some aspect ofS.-J. Lee (Johns Hopkins) presented data showing
cell cycle control is aberrant despite the fact that TGFthat the TGF superfamily member myostatin, a nega-
receptor signaling appears normal. Interestingly, the ab-tive regulator of muscle mass, can act systemically as an
sence of phosphorylated Smad2 in breast and colorectalendocrine hormone. Mouse and cow myostatin mutants
cancers is associated with a significantly worse clinicalexhibit muscle hypertrophy (McPherron et al., 1997;
outcome.McPherron and Lee, 1997). Dr. Lee showed that tumors
Mutations in TGF signaling components also are as-secreting myostatin cause reduction in muscle mass
sociated with diseases other than cancer. For example,
when implanted into mice.
mutations in ALK1 are associated with hereditary hem-
orrhagic telangiectasia, which causes an overprolifera-
tion of vascular tissue (Johnson et al., 1996). Mutations
TGF and Neuronal Functions
in BMPR2 are associated with primary pulmonary hyper-
Little is known about TGF’s role in late neurogenesis.
tension (Machado et al., 2001), but the nature of the
Previous studies in C. elegans have shown a role for signaling defects are unknown. K. Miyazono (U. Tokyo)
UNC-129, a TGF-like molecule, in axonal guidance has been exploring the signaling capacity of the mutated
(Colavita et al., 1998), but this must be just the tip of BMPR2 receptor genes. One class of mutations occurs
the iceberg. However, a new role for TGF has now in the unique long cytoplasmic tail of this receptor. Inter-
been established by Mike O’Connor (U. Minnesota). In estingly, a homolog of this receptor is present in Dro-
Drosophila, most of the functions of the BMP pathway sophila, and it also contains a long cytoplasmic tail.
appear to function through a type II receptor, Punt. Years TGF also plays important roles in function of the
ago, a second type II BMP receptor was identified in immune system. It has long been known as an immuno-
Drosophila, wishful thinking (wit). wit mutations result suppressive agent and helps some tumors escape the
in pharate lethality, which can be rescued completely scrutiny of the immune system. TGF1 knockout mice
by expression of wit in motor neurons of developing have many pleiotropic phenotypes, and R. Flavell (Yale)
Drosophila. Dr. O’Connor presented new data that wanted to examine the effect of loss of TGF signaling
shows that wit mutants affect the structure and function specifically in immune cells. Therefore, his group ex-
of neuromuscular junctions. This suggests the exciting pressed a dominant-negative TGF type II receptor us-
possibility that BMP signaling modulates synaptic plas- ing a T cell-specific promoter and found that transgenic
ticity. cells are resistant to TGF-mediated inhibition of T cell
Clarification of the role of the BMPs in neural crest proliferation. Mice with the transgene were able to clear
formation is underway in the Mullins lab (U. Penn). Neural EL-4 thymomas and a melanoma lung metastasis, which
crest progenitors are absent in BMP2 mutants but are wild-type mice cannot do. J. Roes (University College,
expanded in Smad5 and BMP7 mutants. Lowering BMP London) used cre/lox recombination to remove the
signaling by genetic and other means results in an TGF type II receptor in B cells and found that the rela-
expansion of the neural crest. Thus, it appears that low tive numbers of different types of B cells was altered and
levels of BMP signaling are required for neural crest that the mice were hyperresponsive to weak antigens
specification. Chordin does not seem to modify BMP (Cazac and Roes, 2000).
levels in neural crest. BMP signals are important for
other aspects of neural development, such as the spinal Smads Control Protein Degradation
cord. Loss of BMP2 signaling allows for an expansion Several groups presented studies showing that, in addi-
of interneurons. This highlights a theme that has been tion to acting as transcription factors, Smads can func-
observed in many other signaling events—namely that tion to target proteins to proteosomes. R-Smads and
TGF pathways can play negative and positive roles in I-Smads bind to the Smurf family of C2-WW-Hect do-
development, and this balance is important for proper main ubiquitin ligases. J. Wrana (Lunenfeld Institute,
Toronto) and K. Miyazono (U. Tokyo) presented dataspecification.
Meeting Review
347
that shows that I-Smads recruit the Smurf ligases to the provides an example. FKBP12 can repress TGF signal-
ing in tissue culture cells (Chen et al., 1997), but thereceptor in the plasma membrane, resulting in degrada-
tion of the receptor complex (Ebisawa et al., 2001; Kav- mouse knockout does not have any obvious defects in
processes regulated by known TGF pathways (Shousak et al., 2000). Dr. Miyazono showed that the C2 do-
main of the Smurf is required for the I-Smad/Smurf et al., 1998). Furthermore, X. Sanchez and M. Matzuk
(Baylor College of Medicine) revealed that FKBP12.6complex to be recruited to the plasma membrane and
that this localization is required for the I-Smad to nega- knockout mice and FKBP12/FKBP12.6 double-mutant
mice do not show any obvious defects in TGF-regu-tively regulate signaling. Dr. Wrana also presented data
showing that R-Smads use Smurf to target Sno for deg- lated events. Further examination of these mutant mice
may reveal subtle TGF pathway mutant phenotypes,radation (Bonni et al., 2001), and K. Luo (UC-Berkeley)
has found that the R-Smads can recruit the APC ubiqui- but the role of FKBP12 in TGF signaling, if any, is subtle.
In another case, mouse knockouts of Smad4 raisedtin-protein ligase to cause degradation of Sno.
some questions. Early biochemical work suggested that
Smad4 was required for Activin, BMP, and TGF signal-
Conservation of Signaling Components ing. However, examination of the Smad4 mutant mice
among Organisms suggested that Smad4 is not required downstream of
The core signaling pathway components (ligands, re- BMP4 in embryonic tissue (reviewed in Whitman, 1998),
ceptors, Smads) are found in all animal models. As dis- and examination of Smad4 mutant cell lines indicated
cussed above, the Chordin/BMP/Xolloid complex func- that Smad4 was not required for a subset of TGF-
tions in a similar manner to the one in Drosophila regulated events (Sirard et al., 2000). One potential ex-
involving SOG/DPP/TOLLOID. However, many genes planation for this discrepancy involves another Smad4-
outside the core signaling pathway appear to be less like molecule, such as the one found in Xenopus (Howell
conserved among different phyla, particularly the genes et al., 1999). However, no other mouse or human homo-
that specify the differentiation of specific tissues. Evi- log has not been identified. A second possible solution
dence was presented for conservation of core signaling is that TGF signaling in mice could use a Smad4-inde-
components as well data on new genes where the con- pendent output, as was seen in Hocevar et al. (1999). The
servation was less clear. G. Patterson (Rutgers U.) de- early discrepancies stimulated additional experiments
scribed the cloning of daf-5, a component of a geneti- that led to new insights.
cally complex pathway of TGF signaling, the dauer Smad2 mice die early in embryogenesis. In contrast,
pathway (Patterson and Padgett, 2000). Interestingly, Smad3 mutant mice are viable and fertile but exhibit
DAF-5 has conserved domains present in the Sno/Ski various defects (Datto et al., 1999). This suggests that
family of proteins. Is it the C. elegans version of Sno/ Smad2 plays critical roles in development, whereas
Ski? There is no other Sno/Ski-like protein in C. elegans, Smad3 plays a less important role. Cell culture and mi-
which suggests that this is a bona fide, but highly di- croarray studies of mesenchyme differentiation pre-
verged, Sno/Ski protein. In another branch of the C. sented by R. Derynck and E. Bo¨ttinger (Einstein College
elegans signaling pathway, the Sma/Mab pathway, R. of Medicine) (Zavadil et al., 2001) suggest that Smad3
Padgett (Rutgers U.) and collaborators (D. Merz, Lunen- appears to be more important than Smad2 in this pro-
feld Institute, Toronto) reported on the isolation of cess. It will be interesting to see how the roles of Smad2
schnurri. schnurri was originally identified in Drosophila and Smad3 this event will compare with their roles in
and shown to participate in some dpp functions, as early development.
described above. The involvement of a C. elegans X.-F. Wang (Duke U.) characterized a binding site that
schnurri homolog in TGF signaling in the nematode mediates transcriptional repression by TGF. Remark-
and the finding that Drosophila Brinker can repress BMP ably, this site is completely different from the site that
target genes in Xenopus (Minami et al., 1999) suggests mediates transcriptional activation (the extensively
that the nuclear readout involving Schnurri/Mad-depen- characterized Smad Binding Element [Massague´,
dent Brinker repression as a major signal response 1998]). Several Smad-interacting corepressor molecules
might have been conserved in evolution. There are verte- have been identified (e.g., Sno/Ski, TGIF, Snip1). These
brate schnurri homologs, but their function in TGF sig- are proteins that interact with Smads and alter the ex-
naling has not been examined. However, there are no pression of their target genes in tissue culture assays
C. elegans, mouse, or human brinker orthologs. Given (Zimmerman and Padgett, 2000). The proposed role of
that the primary identified function of schnurri is to re- these proteins is to abrogate, or turn off, the activation of
press brinker expression, it will be interesting to see TGF induced genes. These same corepressor proteins
how schnurri functions in these organisms. may also play a role in the active repression of TGF-
inhibited genes through a potential interaction with
Smads recruited to this novel Smad binding DNA se-Unresolved Issues
quence.Biochemical experiments in cell culture and genetic ex-
periments in animals have their own strengths and weak-
nesses, but combining them often offers additional in- New Approaches and Future Issues
As with any meeting, part of the excitement is to seesights into biological problems. Different approaches
can lead to different models. But the work done to re- how new approaches will provide new insights and to
see work currently at an early stage but with the potentialsolve these differences is always informative and in-
structive. Some issues of this type arose at this meeting. to provide new and exciting discoveries. As with all
biological systems, a more complete understanding ofThe question of the role of FKBP12 in TGF signaling
Developmental Cell
348
how a pathway functions can be obtained from detailed because the effects are numerous and systemic. As
structural/function analysis of participating compo- described above, J. Roes and R. Flavell have used cell
nents. For the last few years, J. Massague´ (Sloan Ketter- type-specific disruptions in TGF signaling to show the
ing) and J. Kuriyan (Rockefeller) have been examining effects of this mutation on B cells and T cells and have
the crystal structure of the type I receptor of the TGF thereby improved our understanding of the role of
superfamily (Huse et al., 1999). The most pressing ques- TGF1 in disease and normal immune function. This
tion regarding the type I receptor is how the GS box type of conditional or cell type-specific knockout will no
functions in activation of downstream signaling. One doubt prove useful in the future for delineating TGF
problem in solving this puzzle is to obtain purified forms signaling functions.
of the phosphorylated form of the GS domain in the It was generally felt that a meeting that focused on
context of the type I kinase. Dr. Massague´ discussed developmental consequences of TGFwas overdue and
work done with T. Muir (Rockefeller U.) chemically syn- so this meeting was received with enthusiasm. Based
thesizing a phosphorylated GS box onto a type I receptor on this success, plans are now to continue it every two
so that pure forms of this protein can be used in struc- years. Given that many labs are beginning to focus on
tural studies (Huse et al., 2001). These studies indicate normal and abnormal developmental consequences of
that phosphorylation of the GS box alters the interaction TGF signaling, we anticipate an interesting meeting in
of the receptor with Smad2 and the inhibitor FKBP12. two years.
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